PUBLISHER: The Business Research Company | PRODUCT CODE: 1948358
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948358
Transcranial magnetic stimulators (TMS) are non-invasive medical devices that utilize magnetic waves to activate neurons in the nervous system, aiming to alleviate symptoms of depression and other mental health and brain-related disorders. These devices are employed to stimulate neurons in the nervous system for therapeutic purposes.
The primary types of transcranial magnetic stimulators include deep transcranial magnetic stimulators (dTMS), repetitive TMS (rTMS), and other variations. Deep Transcranial Magnetic Stimulator (dTMS) is a specific type of transcranial magnetic stimulation (TMS) therapy utilizing magnetic fields to stimulate nerve cells in the brain, effectively addressing symptoms of depression. This form of therapy is applicable to both children and adults and finds use in diverse applications such as Parkinson's disease, depression, Alzheimer's disease, epilepsy, and more.
Tariffs are impacting the transcranial magnetic stimulator market by increasing costs of imported magnetic coils, electronic control systems, cooling components, and precision manufacturing equipment. Mental health clinics and hospitals in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher system pricing and distribution costs. These tariffs are increasing capital investment requirements for providers. However, they are also encouraging local device assembly, regional manufacturing capabilities, and innovation in cost-efficient neuromodulation systems.
The transcranial magnetic stimulator market research report is one of a series of new reports from The Business Research Company that provides transcranial magnetic stimulator market statistics, including transcranial magnetic stimulator industry global market size, regional shares, competitors with a transcranial magnetic stimulator market share, detailed transcranial magnetic stimulator market segments, market trends and opportunities, and any further data you may need to thrive in the transcranial magnetic stimulator industry. This transcranial magnetic stimulator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The transcranial magnetic stimulator market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of depression and neurological disorders, growing awareness of non-pharmacological therapies, availability of FDA-approved tms systems, expansion of mental health clinics, rising acceptance of neuromodulation therapies.
The transcranial magnetic stimulator market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing adoption of tms for broader neurological indications, rising demand for personalized mental health treatments, expansion of outpatient psychiatric care, growing integration of digital treatment monitoring, increasing investments in neuromodulation research. Major trends in the forecast period include increasing adoption of non-invasive brain stimulation therapies, rising use of rtms in depression treatment, growing expansion of dtms clinical applications, enhanced focus on personalized neurostimulation protocols, expansion of outpatient mental health treatments.
The growth of the transcranial magnetic stimulator market is expected to be fueled by the increasing prevalence of neurological diseases. Transcranial magnetic stimulation (TMS) has demonstrated promising outcomes in the treatment of various neurological and psychiatric disorders, offering a novel approach to addressing conditions such as stroke, spasticity, migraine, dementia, and movement disorders. For example, in March 2023, the World Health Organization (WHO) reported that approximately 280 million people worldwide were affected by depression. Hence, the growing prevalence of neurological diseases is anticipated to drive the growth of the transcranial magnetic stimulator market.
Major companies operating in the transcranial magnetic stimulator market are focusing on developing innovative advancements such as neuronavigational-guided TMS systems to improve coil placement accuracy, enhance treatment consistency, and streamline clinical workflows. A neuronavigational-guided TMS system refers to an image-based guidance platform that integrates patient-specific neuroimaging with real-time coil tracking to ensure precise and reproducible stimulation targeting during transcranial magnetic stimulation procedures. For example, in March 2023, MagVenture Inc., a US-based medical equipment manufacturer, introduced the MagVenture TMS Atlas Neuro Navigation System. This system enhances transcranial magnetic stimulator coil positioning through a time-saving, high-precision workflow that is both reliable and user-friendly. The Atlas system provides high precision and accuracy for clinical use, offering operators a greater range of movement during TMS treatments by eliminating line-of-sight concerns. It utilizes advanced technology to provide patients with a visual representation of their MRI scan and real-time tracking of the treatment coil to their head position, enabling their active participation in the procedure.
In December 2024, Neuronetics, Inc., a US-based provider of transcranial magnetic stimulation systems and neurotechnology solutions for mental health treatment, acquired Greenbrook TMS Inc. for an undisclosed amount. Through this acquisition, Neuronetics aims to expand its treatment network, strengthen its commercial presence, and accelerate access to transcranial magnetic stimulation therapies by integrating a large clinical service infrastructure with its technology platform. Greenbrook TMS Inc., based in Canada, provides outpatient transcranial magnetic stimulation services through a nationwide network of mental health treatment centers.
Major companies operating in the transcranial magnetic stimulator market are BrainsWay Ltd., Nexstim Plc., The Magstim Company Limited, Neuronetics Inc., MagVenture Inc., MAG & More GmbH, neurocare group AG, Neurosoft, Neuroelectrics, NeuroConn GmbH, Neurofield Inc., Axilum Robotics, Yiruide Neurotech, Brainbox Ltd., Remed Inc., Soterix Medical Inc., Sinovation Medical Technology Co. Ltd., Shenzhen Yingchi Technology Co. Ltd., Wuhan Greentek Bioengineering Co. Ltd., Vishee Medical Technology Co. Ltd.
North America was the largest region in the transcranial magnetic stimulator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global transcranial magnetic stimulator market report during the forecast period. The regions covered in the transcranial magnetic stimulator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the transcranial magnetic stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The transcranial magnetic stimulator market consists of sales of single-pulse and paired-pulse transcranial magnetic stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Transcranial Magnetic Stimulator Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses transcranial magnetic stimulator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for transcranial magnetic stimulator ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcranial magnetic stimulator market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.